Results 201 to 210 of about 42,942 (233)

Circulating sPD-L1 as a tumor microenvironment-derived biomarker: enhancing diagnostic discrimination accuracy in breast cancer. [PDF]

Cancer Immunol Immunother
Zhang Y, Chen S, Ma J, Sun X, Zhou X.
europepmc   +1 more source

Diagnostic and prognostic values of circulating growth differentiation factor-15 and osteopontin in uterine sarcoma. [PDF]

Sci Rep
Tsuyoshi H, Mizutani T, Uno M, Kato T, Orisaka M, Yoshida Y.   +5 more
europepmc   +1 more source

Clinical characteristics and prognostic factors of ovarian granulosa cell tumors: a retrospective cohort study. [PDF]

Front Oncol
Fan Y, Zeng Y.
europepmc   +1 more source

Early capecitabine metronomic chemotherapy improves patient prognosis and safety in early-stage triple-negative breast cancer. [PDF]

Am J Transl Res
Sun Y, Shang J, Duan K, Song Y, Yang Z.
europepmc   +1 more source

Expression of CA125 in adenomyosis

Polish Journal of Pathology, 1995
Goluda, Marian, Ujec, Mieczysław
openaire  

Metformin combined with progesterone improves efficacy and reduces adverse reactions in early endometrial cancer. [PDF]

Am J Transl Res
Li J, Hou Y, Liao D.
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

CA125 and endometriosis

Human Reproduction Update, 1995
This review covers the literature on CA125 and endometriosis; data on CA125 and oncology are not discussed. In normal women, plasma concentrations of CA125 are increased slightly at ovulation and significantly during menstruation. Marked increases are observed during pregnancy and following peritoneal irritation by infection or surgery.
M, Muyldermans, F J, Cornillie, P R, Koninckx   +2 more
openaire   +2 more sources

Smartphone-based immunosensor for CA125 detection

Talanta, 2017
In this work, we report the design, the development and the characterization of the analytical performances of a colorimetric smartphone-based immunosensor for the detection of cancer antigen 125 (CA125). The immunosensor was based on a sandwich strategy in which the primary antibody was immobilized by spotting onto the 3D nitrocellulose membrane.
HOSU, OANA ALEXANDRA, Ravalli, Andrea, Lo Piccolo, Giuseppe Mattia, Cristea, Cecilia, Sandulescu, Robert, Marrazza, Giovanna   +5 more
openaire   +3 more sources

Clinical evaluation of new cancer-associated antigen CA125 II in epithelial ovarian cancers: Comparison with CA125

Clinical Biochemistry, 1993
With use of monoclonal antibodies (moABs) M 11 and OC125, a sensitive sandwich immunoradiometric assay (IRMA) for CA125 II was developed. CA125 antigen was adsorbed by moAB OC125 and M 11, but horseradish peroxidase-labelled OC125 did not compete with M 11, indicating that although these two moABs recognized CA125 antigen, they reacted with separate ...
H, Kobayashi, M, Tamura, T, Satoh, T, Terao   +3 more
openaire   +2 more sources